Progress in therapeutic targets on podocyte for Alport syndrome
- PMID: 38812923
- PMCID: PMC11135632
- DOI: 10.2478/jtim-2024-0005
Progress in therapeutic targets on podocyte for Alport syndrome
Keywords: Alport syndrome; podocyte; therapeutic targets.
Conflict of interest statement
Conflict of Interest None declared.
Figures
References
-
- Kashtan CE, Ding J, Garosi G, Heidet L, Massella L, Nakanishi K. Alport syndrome: a unified classification of genetic disorders of collagen IV α345: a position paper of the Alport Syndrome Classification Working Group. Kidney Int. 2018;93:1045. et al. –. - PubMed
-
- Xie J, Wu X, Ren H, Wang W, Wang Z, Pan X. COL4A3 mutations cause focal segmental glomerulosclerosis. J Mol Cell Biol. 2014;6:498. et al. –. - PubMed
LinkOut - more resources
Full Text Sources